USP17L2 and cancer: First, we identify the CK2α-DUB3 axis as an uncharacterized upstream signaling pathway regulating cellular YAP1 abundance in multiple cancer types including ovarian cancer, which critically contributes to tumor progression and chemotherapy resistance.